Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) EBIT Margin (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed EBIT Margin for 5 consecutive years, with 972.62% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin rose 2516.0% year-over-year to 972.62%, compared with a TTM value of 1103.31% through Sep 2025, down 2594.0%, and an annual FY2024 reading of 1070.98%, up 92581.0% over the prior year.
  • EBIT Margin was 972.62% for Q3 2025 at Lucid Diagnostics, up from 978.85% in the prior quarter.
  • Across five years, EBIT Margin topped out at 4092.52% in Q2 2021 and bottomed at 18917.11% in Q3 2022.
  • Average EBIT Margin over 5 years is 3671.72%, with a median of 1283.96% recorded in 2023.
  • The sharpest move saw EBIT Margin plummeted -1566211bps in 2022, then soared 1749590bps in 2023.
  • Year by year, EBIT Margin stood at 3255.0% in 2021, then tumbled by -312bps to 13400.0% in 2022, then soared by 92bps to 1101.25% in 2023, then rose by 2bps to 1075.15% in 2024, then grew by 10bps to 972.62% in 2025.
  • Business Quant data shows EBIT Margin for LUCD at 972.62% in Q3 2025, 978.85% in Q2 2025, and 1508.09% in Q1 2025.